SCHEMBL10025828

SCHEMBL10025828

O=c1oc2ccccc2oc(=O)c2ccccc2c2c3ccccc3c(c3ccccc13)c1ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.60
TDP1 Q9NUW8 1/20 0.60
ALDH1A1 P00352 6/20 0.52
KDM4E B2RXH2 4/20 0.52
GAA P10253 1/20 0.52
CDC25A P30304 1/20 0.51
CDC25B P30305 1/20 0.51
CDC25C P30307 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.50
NPSR1 Q6W5P4 3/20 0.50
MAPT P10636 3/20 0.50
KMT2A Q03164 3/20 0.50
GLA P06280 2/20 0.50
HSD17B10 Q99714 2/20 0.50
RXFP1 Q9HBX9 2/20 0.50
MAPK1 P28482 2/20 0.50
CYP3A4 P08684 2/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
HPGD P15428 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10025819 0.93 L3MBTL1 (0.69) L3MBTL1TDP1ALDH1A1KDM4EGAA
SCHEMBL29416517 0.83 KMT2A (0.62) L3MBTL1TDP1ALDH1A1KDM4EGAA
SCHEMBL304367 0.83 KMT2A (0.62) L3MBTL1TDP1ALDH1A1KDM4EGAA
SCHEMBL29709713 0.83 KMT2A (0.62) L3MBTL1TDP1ALDH1A1KDM4EGAA
SCHEMBL31408194 0.81 MAOA (0.62) L3MBTL1TDP1ALDH1A1KDM4EGAA
SCHEMBL21249169 0.81 L3MBTL1 (0.47) L3MBTL1TDP1ALDH1A1KDM4EGAA
SCHEMBL16925879 0.81 L3MBTL1 (0.47) L3MBTL1TDP1ALDH1A1KDM4EGAA
SCHEMBL4430606 0.81 MAOA (0.62) L3MBTL1TDP1ALDH1A1KDM4EGAA
SCHEMBL17177077 0.81 KDM4E (0.49) L3MBTL1TDP1ALDH1A1KDM4EGAA
SCHEMBL6650775 0.81 ALDH1A1 (0.53) L3MBTL1TDP1ALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124249-B2 Derivatives of fused aromatic systems; stability; sublimation stability; easy to purify due to better solubilty; easy reproducibility because do not form isomers MERCK PATENT GMBH (DE) 2012-02-28 US disclosed
US-8124249-B2 Derivatives of fused aromatic systems; stability; sublimation stability; easy to purify due to better solubilty; easy reproducibility because do not form isomers MERCK PATENT GMBH (DE) 2012-02-28 US disclosed
US-20080171225-A1 Novel Materials For Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-07-17 US disclosed
US-20080171225-A1 Novel Materials For Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080171225-A1 Novel Materials For Organic Electroluminescent Devices OR10J3, EML4, TYR L3MBTL1 1759/4885TDP1 1990/4885ALDH1A1 1325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.